BioMarin Pharmaceutical Inc. buy Morgan Stanley
Start price
28.10.25
/
50%
€46.90
Target price
28.10.26
€84.06
Performance (%)
14.41%
Price
14:59
€53.66
Summary
This prediction is currently active. The prediction currently has a performance of 14.41%. This prediction currently runs until 28.10.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| BioMarin Pharmaceutical Inc. | 5.138% | 5.138% |
| iShares Core DAX® | 0,02 % | 0,58 % |
| iShares Nasdaq 100 | 1,74 % | -2,06 % |
| iShares Nikkei 225® | 0,43 % | 10,49 % |
| iShares S&P 500 | 1,33 % | 0,14 % |
Comments by Morgan_Stanley for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical (NASDAQ:BMRN) had its price target lowered by analysts at Morgan Stanley from $104.00 to $98.00. They now have an "overweight" rating on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Morgan_Stanley for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€50.36
22.07.25
22.07.25
€82.12
22.07.26
22.07.26
6.55%
14:59
14:59
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€48.80
03.07.25
03.07.25
€82.17
03.07.26
03.07.26
9.96%
14:59
14:59
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€75.64
26.04.24
26.04.24
€104.69
26.04.25
26.04.25
-26.63%
27.04.25
27.04.25
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€79.72
01.08.23
01.08.23
€113.91
01.08.24
01.08.24
-3.59%
02.08.24
02.08.24